Tags

Type your tag names separated by a space and hit enter

Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018.
MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.MM

Abstract

In the fall of 2014, an outbreak of enterovirus D68 (EV-D68)-associated acute respiratory illness (ARI) occurred in the United States (1,2); before 2014, EV-D68 was rarely reported to CDC (2,3). In the United States, reported EV-D68 detections typically peak during late summer and early fall (3). EV-D68 epidemiology is not fully understood because testing in clinical settings seldom has been available and detections are not notifiable to CDC. To better understand EV-D68 epidemiology, CDC recently established active, prospective EV-D68 surveillance among pediatric patients at seven U.S. medical centers through the New Vaccine Surveillance Network (NVSN) (4). This report details a preliminary characterization of EV-D68 testing and detections among emergency department (ED) and hospitalized patients with ARI at all NVSN sites during July 1-October 31, 2017, and the same period in 2018. Among patients with ARI who were tested, EV-D68 was detected in two patients (0.8%) in 2017 and 358 (13.9%) in 2018. Continued active, prospective surveillance of EV-D68-associated ARI is needed to better understand EV-D68 epidemiology in the United States.

Links

Publisher Full Text
ncbi.nlm.nih.gov
doi.org
PMC Free PDF

Authors

Kujawski SA
No affiliation info available
Midgley CM
No affiliation info available
Rha B
No affiliation info available
Lively JY
No affiliation info available
Nix WA
No affiliation info available
Curns AT
No affiliation info available
Payne DC
No affiliation info available
Englund JA
No affiliation info available
Boom JA
No affiliation info available
Williams JV
No affiliation info available
Weinberg GA
No affiliation info available
Staat MA
No affiliation info available
Selvarangan R
No affiliation info available
Halasa NB
No affiliation info available
Klein EJ
No affiliation info available
Sahni LC
No affiliation info available
Michaels MG
No affiliation info available
Shelley L
No affiliation info available
McNeal M
No affiliation info available
Harrison CJ
No affiliation info available
Stewart LS
No affiliation info available
Lopez AS
No affiliation info available
Routh JA
No affiliation info available
Patel M
No affiliation info available
Oberste MS
No affiliation info available
Watson JT
No affiliation info available
Gerber SI
No affiliation info available

MeSH

AdolescentChildChild, PreschoolDisease OutbreaksEnterovirus D, HumanEnterovirus InfectionsFemaleHumansInfantMalePopulation SurveillanceRespiratory Tract InfectionsUnited States

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30921299

Citation

Kujawski, Stephanie A., et al. "Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018." MMWR. Morbidity and Mortality Weekly Report, vol. 68, no. 12, 2019, pp. 277-280.
Kujawski SA, Midgley CM, Rha B, et al. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019;68(12):277-280.
Kujawski, S. A., Midgley, C. M., Rha, B., Lively, J. Y., Nix, W. A., Curns, A. T., Payne, D. C., Englund, J. A., Boom, J. A., Williams, J. V., Weinberg, G. A., Staat, M. A., Selvarangan, R., Halasa, N. B., Klein, E. J., Sahni, L. C., Michaels, M. G., Shelley, L., McNeal, M., ... Gerber, S. I. (2019). Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR. Morbidity and Mortality Weekly Report, 68(12), 277-280. https://doi.org/10.15585/mmwr.mm6812a1
Kujawski SA, et al. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29;68(12):277-280. PubMed PMID: 30921299.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. AU - Kujawski,Stephanie A, AU - Midgley,Claire M, AU - Rha,Brian, AU - Lively,Joana Y, AU - Nix,W Allan, AU - Curns,Aaron T, AU - Payne,Daniel C, AU - Englund,Janet A, AU - Boom,Julie A, AU - Williams,John V, AU - Weinberg,Geoffrey A, AU - Staat,Mary A, AU - Selvarangan,Rangaraj, AU - Halasa,Natasha B, AU - Klein,Eileen J, AU - Sahni,Leila C, AU - Michaels,Marian G, AU - Shelley,Lynne, AU - McNeal,Monica, AU - Harrison,Christopher J, AU - Stewart,Laura S, AU - Lopez,Adriana S, AU - Routh,Janell A, AU - Patel,Manisha, AU - Oberste,M Steven, AU - Watson,John T, AU - Gerber,Susan I, Y1 - 2019/03/29/ PY - 2019/3/29/entrez PY - 2019/3/29/pubmed PY - 2019/3/30/medline SP - 277 EP - 280 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 68 IS - 12 N2 - In the fall of 2014, an outbreak of enterovirus D68 (EV-D68)-associated acute respiratory illness (ARI) occurred in the United States (1,2); before 2014, EV-D68 was rarely reported to CDC (2,3). In the United States, reported EV-D68 detections typically peak during late summer and early fall (3). EV-D68 epidemiology is not fully understood because testing in clinical settings seldom has been available and detections are not notifiable to CDC. To better understand EV-D68 epidemiology, CDC recently established active, prospective EV-D68 surveillance among pediatric patients at seven U.S. medical centers through the New Vaccine Surveillance Network (NVSN) (4). This report details a preliminary characterization of EV-D68 testing and detections among emergency department (ED) and hospitalized patients with ARI at all NVSN sites during July 1-October 31, 2017, and the same period in 2018. Among patients with ARI who were tested, EV-D68 was detected in two patients (0.8%) in 2017 and 358 (13.9%) in 2018. Continued active, prospective surveillance of EV-D68-associated ARI is needed to better understand EV-D68 epidemiology in the United States. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/30921299/Enterovirus_D68_Associated_Acute_Respiratory_Illness___New_Vaccine_Surveillance_Network_United_States_July_October_2017_and_2018_ L2 - https://doi.org/10.15585/mmwr.mm6812a1 DB - PRIME DP - Unbound Medicine ER -